Téléchargement de Livres Blancs
In an industry shaped by ever-increasing regulation, global competition and market expectations, research-based biopharmaceutical organizations need ways to improve the efficiency and productivity of drug development processes. Traditional information management practices—constrained by manual data transfer, workflow and audit procedures—are not measuring up. This white paper describes SAS® Drug Development, which provides a unified platform for bringing consistency, control and compliance to information processes, from data aggregation through analysis and reporting to FDA submission.
Vous avez déjà votre profil SAS ? Connectez-vous en utilisant le formulaire pré-rempli.